Ramaswamy Govindan MD

Professor, Internal Medicine, Washington University School of Medicine

4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 800-647-2098
Fax+1 314-362-3192

Dr. Govindan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Govindan's full profile Already have an account?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1993 - 1996
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1991 - 1993
Stanley Medical College SMCClass of 1987

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MO State Medical License 1995 - 2027
IL State Medical License 1996 - 1999
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2017
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2013-2017
CMS Meaningful Use Stage 1 Certification Follow My Health, Jardogs, 2013-2017

Clinical Trials

Gefitinib in Treating Patients With Malignant Mesothelioma
COMPLETED
PHASE2
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
COMPLETED
PHASE2
Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer
COMPLETED
PHASE2

Publications & Presentations

PubMed

Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
Jamie E Chaft, Zhuoxin Sun, Charles M Rudin, Onkar V Khullar, Charles B Simone 2nd
JAMA. 2026-08-11
New Lungs for Lung Cancer-Perils and Promises.
Ece Cali Daylan, Ramaswamy Govindan
JAMA. 2026-08-11
Biological aging and generational shifts in early-onset cancer risk.
Ruiyi Tian, Xiaoyu Zong, Duo Ren, Stefani Tica, Daniel Hong
Nature Medicine. 2026-08-01

Journal Articles

A Deep Learning Approach to Automate Refinement of Somatic Variant Calling from Cancer Sequencing Data
Ravindra Uppaluri, Gavin P Dunn, Ramaswamy Govindan, S Joshua Swamidass, Todd A Fehniger, Nature
Targeting Resistance to Targeted Therapies: Combating a Resilient Foe
Siddhartha Devarakonda, Ramaswamy Govindan, Clinical Cancer Research
Recurrent WNT Pathway Alterations Are Frequent in Relapsed Small Cell Lung Cancer
Saiama N. Waqar, Daniel Morgensztern, Robert S. Fulton, Ramaswamy Govindan, Nature

Lectures

An open-label, phase 1b study of NEO-PV-01 with pembrolizumab plus chemotherapy in patients with advanced or metastatic nonsquamous non-small cell lung cancer.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Great Debates and Updates In Thoracic Malignancies
Imedex, San Francisco, California - 5/5/2012

Press Mentions

Washington University School of Medicine Investigators Probe Gene & Protein-Level Patterns Behind Lung Cancer RecurrenceJune 30th, 2022
$5.3M Grant Funds Washington University School of Medicine Lung Cancer Recurrence ResearchJune 29th, 2022
$5.3 Million Grant Supports Research into Lung Cancer RecurrenceJune 28th, 2022

Grant Support

Washington University PDX Development and Trial CenterWASHINGTON UNIVERSITY2017–2028
Proteogenomic Predictors of Recurrence in Non-small Cell Lung CancerWASHINGTON UNIVERSITY2022–2027
Washington University Paul Calabresi K12 Career Development Award for Clinical OncologyWASHINGTON UNIVERSITY2012–2027
Deep exploration of drivers, evolution, and microenvironment toward discovering principal themes in cancerWASHINGTON UNIVERSITY2021–2026
Deep exploration of drivers, evolution, and microenvironment toward discovering principal themes in cancerWASHINGTON UNIVERSITY2021–2026

Committees

Member, International Association for the Study of Lung Cancer Core Program 2014 - Present
Member, ALCHEMIST Champions Team 2014 - Present
Member, SITC/Medscape CME Project Steering Committee 2014 - Present
Member, National Comprehensive Cancer Network (NCCN) National Cancer Institute (NCI) Non-Small Cell Lung Cancer Panel 2013 - Present
Chair, IASLC Pathology Committee 2012 - Present